Basic Info

Common NameEthylphosphate(F05531)
2D Structure
Description

Ethylphosphate is produced by the reaction between diethylphosphate and water, with ethanol as a byproduct.

FRCD IDF05531
CAS Number78-40-0
PubChem CID6535
FormulaC6H15O4P
IUPAC Name

triethyl phosphate

InChI Key

DQWPFSLDHJDLRL-UHFFFAOYSA-N

InChI

InChI=1S/C6H15O4P/c1-4-8-11(7,9-5-2)10-6-3/h4-6H2,1-3H3

Canonical SMILES

CCOP(=O)(OCC)OCC

Isomeric SMILES

CCOP(=O)(OCC)OCC

Synonyms
        
            Phosphoric acid, triethyl ester
        
            TRIETHYL PHOSPHATE
        
            78-40-0
        
            Triethylphosphate
        
            Tris(ethyl) phosphate
        
            Triethoxyphosphine oxide
        
            Triethylfosfat
        
            Ethyl phosphate ((EtO)3PO)
        
            Triethylfosfat [Czech]
        
            Ethyl phosphate (VAN)
        
Classifies
                

                  
                    Predicted: Pesticide
                  

                
        
Update DateNov 13, 2018 17:07

Chemical Taxonomy

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
ClassOrganic phosphoric acids and derivatives
SubclassPhosphate esters
Intermediate Tree NodesAlkyl phosphates
Direct ParentTrialkyl phosphates
Alternative Parents
Molecular FrameworkAliphatic acyclic compounds
SubstituentsTrialkyl phosphate - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Aliphatic acyclic compound
DescriptionThis compound belongs to the class of organic compounds known as trialkyl phosphates. These are organic compounds containing a phosphate group that is linked to exactly three alkyl chains.

Properties

Property NameProperty Value
Molecular Weight182.156
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count6
Complexity113
Monoisotopic Mass182.071
Exact Mass182.071
XLogP0.8
Formal Charge0
Heavy Atom Count11
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

ADMET

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.9215
Human Intestinal AbsorptionHIA+0.9640
Caco-2 PermeabilityCaco2-0.5303
P-glycoprotein SubstrateNon-substrate0.7973
P-glycoprotein InhibitorNon-inhibitor0.8140
Non-inhibitor0.8565
Renal Organic Cation TransporterNon-inhibitor0.9310
Distribution
Subcellular localizationMitochondria0.7252
Metabolism
CYP450 2C9 SubstrateNon-substrate0.8669
CYP450 2D6 SubstrateNon-substrate0.8498
CYP450 3A4 SubstrateNon-substrate0.6040
CYP450 1A2 InhibitorNon-inhibitor0.9228
CYP450 2C9 InhibitorNon-inhibitor0.8962
CYP450 2D6 InhibitorNon-inhibitor0.9403
CYP450 2C19 InhibitorNon-inhibitor0.8806
CYP450 3A4 InhibitorNon-inhibitor0.9283
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.8831
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.8160
Non-inhibitor0.9382
AMES ToxicityNon AMES toxic0.9133
CarcinogensCarcinogens 0.8020
Fish ToxicityHigh FHMT0.6025
Tetrahymena Pyriformis ToxicityHigh TPT0.7492
Honey Bee ToxicityHigh HBT0.9135
BiodegradationNot ready biodegradable0.8418
Acute Oral ToxicityIII0.8798
Carcinogenicity (Three-class)Non-required0.5395

Model Value Unit
Absorption
Aqueous solubility-1.1362LogS
Caco-2 Permeability0.3978LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity2.6232LD50, mol/kg
Fish Toxicity2.0415pLC50, mg/L
Tetrahymena Pyriformis Toxicity-0.5501pIGC50, ug/L

Targets

General Function:
Zinc ion binding
Specific Function:
Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.
Gene Name:
ESR1
Uniprot ID:
P03372
Molecular Weight:
66215.45 Da
References
  1. Sipes NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ, Kavlock RJ, Knudsen TB: Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013 Jun 17;26(6):878-95. doi: 10.1021/tx400021f. Epub 2013 May 16. [23611293 ]